PD Dr. Carolin Hack



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer (2025) Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, et al. Journal article Cross-sectional study on user requirements for developing a digital patient navigator app (2025) Seitz K, Langbein M, Goossens C, Altmannshofer S, Fasching P, Hack C, Heindl F, et al. Journal article Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer (2025) Michel LL, Ziegler P, Kreis P, Hartkopf AD, Wallwiener M, Häberle L, John N, et al. Journal article Impact of risk and lifestyle factors on therapy goals in the treatment of breast cancer and gynecological cancer patients with integrative medicine (2025) Seitz K, Theuser AK, Antoniadis S, Beckmann M, Beierlein M, Brückner L, Au K, Hack C Journal article Cell-free tumor DNA analysis in advanced or metastatic breast cancer patients: mutation frequencies, testing intention, and clinical impact (2025) Hübner H, Wimberger P, Laakmann E, Ruckhäberle E, Rübner M, Lehle S, Uhrig S, et al. Journal article Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological Cancer (2025) Seitz K, Theuser AK, Hack C, Fasching P, Emons J, Brückner L, Au K, et al. Journal article Evaluating the potential of ChatGPT for patient identification in clinical breast cancer trials (2025) Krückel A, Fasching P, Schleicher O, Gocke J, Brückner L, Seitz K, Häberle L, et al. Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article Integration von Komplementärmedizin in die Uroonkologie (2025) Hack C, Seitz K, Thederan I, Wüfling P, Wullich B, Bellut L, Herrmann HJ, Zopf Y Journal article Evaluation and feasibility of diagnostic heatflow imaging in patients with palpable breast lesions: a pilot study (2025) Pöschke P, Boese A, Seitz K, Amann N, Eckstein S, Schulmeyer C, Hack C, et al. Journal article